A model for harmonizing flow cytometry in clinical trials.

Journal Article (Journal Article)

Complexities in sample handling, instrument setup and data analysis are barriers to the effective use of flow cytometry to monitor immunological parameters in clinical trials. The novel use of a central laboratory may help mitigate these issues.

Full Text

Duke Authors

Cited Authors

  • Maecker, HT; McCoy, JP; FOCIS Human Immunophenotyping Consortium, ; Amos, M; Elliott, J; Gaigalas, A; Wang, L; Aranda, R; Banchereau, J; Boshoff, C; Braun, J; Korin, Y; Reed, E; Cho, J; Hafler, D; Davis, M; Fathman, CG; Robinson, W; Denny, T; Weinhold, K; Desai, B; Diamond, B; Gregersen, P; Di Meglio, P; Nestle, FO; Peakman, M; Villanova, F; Ferbas, J; Field, E; Kantor, A; Kawabata, T; Komocsar, W; Lotze, M; Nepom, J; Ochs, H; O'Lone, R; Phippard, D; Plevy, S; Rich, S; Roederer, M; Rotrosen, D; Yeh, J-H

Published Date

  • November 2010

Published In

Volume / Issue

  • 11 / 11

Start / End Page

  • 975 - 978

PubMed ID

  • 20959798

Pubmed Central ID

  • PMC3400260

Electronic International Standard Serial Number (EISSN)

  • 1529-2916

Digital Object Identifier (DOI)

  • 10.1038/ni1110-975


  • eng

Conference Location

  • United States